Transforming growth factor-β regulation of immune responses

MO Li, YY Wan, S Sanjabi, AKL Robertson… - Annu. Rev …, 2006 - annualreviews.org
Transforming growth factor-β (TGF-β) is a potent regulatory cytokine with diverse effects on
hemopoietic cells. The pivotal function of TGF-β in the immune system is to maintain …

Tissue-specific differentiation of CD8+ resident memory T cells

K Yang, A Kallies - Trends in Immunology, 2021 - cell.com
CD8+ tissue-resident memory T (T RM) cells play crucial roles in defense against infections
and cancer and have been implicated in autoimmune diseases such as psoriasis. In mice …

Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity

SN Christo, M Evrard, SL Park, LC Gandolfo… - Nature …, 2021 - nature.com
Tissue-resident memory T (TRM) cells are non-recirculating cells that exist throughout the
body. Although TRM cells in various organs rely on common transcriptional networks to …

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as …

RB Holmgaard, DA Schaer, Y Li, SP Castaneda… - … for immunotherapy of …, 2018 - Springer
Background TGFβ signaling plays a pleotropic role in tumor biology, promoting tumor
proliferation, invasion and metastasis, and escape from immune surveillance. Inhibiting …

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

A Hochhaus, HM Kantarjian, M Baccarani, JH Lipton… - Blood, 2007 - ashpublications.org
Although imatinib induces marked responses in patients with chronic myeloid leukemia
(CML), resistance is increasingly problematic, and treatment options for imatinib-resistant or …

Extracellular vesicles over adeno-associated viruses: Advantages and limitations as drug delivery platforms in precision medicine

N Yom-Tov, R Guy, D Offen - Advanced Drug Delivery Reviews, 2022 - Elsevier
Tissue-specific uptake and sufficient biodistribution are central goals in drug development.
Crossing the blood–brain barrier (BBB) represents a major challenge in delivering …

Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapy

L Li, JR Wei, J Dong, QG Lin, H Tang, YX Jia, W Tan… - Science …, 2021 - science.org
PD-1/PD-L1 blockade therapies provide notable clinical benefits for patients with advanced
cancers, but the factors influencing the effectiveness of the treatment remain incompletely …

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes

C Zhou, B Yang, Y Tian, H Jiao, W Zheng, J Wang… - Cellular …, 2011 - Elsevier
Studies have shown that mesenchymal stem cells (MSCs) have low immunogenicity and
immune regulation. Human umbilical cord Wharton's jelly provides a new source for MSCs …

The impact of CD4+ CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer

K Khazaie, H Von Boehmer - Seminars in cancer biology, 2006 - Elsevier
There is sufficient evidence to suggest that tumor growth elicits specific immune responses,
including CD8+ and CD4+ T cell responses that may delay tumor growth and could …

Transforming growth factor β (TGF-β) and autoimmunity

CA Aoki, AT Borchers, M Li, RA Flavell, CL Bowlus… - Autoimmunity …, 2005 - Elsevier
TGF-β1 deficient mice develop multifocal inflammatory autoimmune disease and serve as a
valuable animal model of autoimmunity. Transgenic expression of a dominant negative form …